Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents used in Patients with Cardiovascular Disease
Published: October 17, 2016
A review of drug-drug interactions with statins and other selected drugs used in patients with cardiovascular disease
- Statins play an important role in clinical management of those at a high risk for atherosclerotic cardiovascular disease and those with atherosclerotic cardiovascular disease.
- The likelihood of these patients taking multiple medications is high, and the possibility for significant drug-drug interactions (DDI’s) should be considered in patients taking statins.
- This statement helps to inform clinicians, optimize management, and minimize drug-drug interactions.
Supporting Materials
- Commentary: Beyond Recommendations and Guidelines: A Need for Closer Collaborations Between Clinician and Clinical Pharmacologist to Better Prevent Drug-Drug Interactions by Dominique Deplanque, MD, PhD
- Top Things to Know: Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents used in Patients with Cardiovascular Disease
- AHA News: AHA statement: Manage interactions with statins, heart disease drugs
- News Release - New statement provides guidance about potential interactions between statins and commonly prescribed heart disease drugs